Trials / Unknown
UnknownNCT03947645
Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients
Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients With Severe Motor Impairment of the Upper Extremity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere.
Detailed description
Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity and non-proportional recovery will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere. The primary outcome measure is the Fugl-Meyer Assessment for upper extremity (FM-UE), acquired at baseline, after the intervention period, and at 3 months follow-up. Secondary outcome measures consist of further clinical parameters and biomarkers of corticospinal connectivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ipsilesional stimulation | Device: ipsilesional transcranial stimulation, neuromuscular Stimulation over target muscle |
| DEVICE | Contralesional stimulation | Device: contralesional transcranial stimulation, neuromuscular stimulation over target muscle |
Timeline
- Start date
- 2019-05-02
- Primary completion
- 2022-02-01
- Completion
- 2022-12-01
- First posted
- 2019-05-13
- Last updated
- 2021-09-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03947645. Inclusion in this directory is not an endorsement.